Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 26 |
| List of Tables | 24 | 3 |
| List of Figures | 27 | 1 |
| Introduction | 28 | 1 |
| Global Markets Direct Report Coverage | 28 | 1 |
| Malaria Overview | 29 | 1 |
| Therapeutics Development | 30 | 2 |
| Pipeline Products for Malaria Overview | 30 | 1 |
| Pipeline Products for Malaria Comparative Analysis | 31 | 1 |
| Malaria Therapeutics under Development by Companies | 32 | 5 |
| Malaria Therapeutics under Investigation by Universities/Institutes | 37 | 4 |
| Malaria Pipeline Products Glance | 41 | 3 |
| Late Stage Products | 41 | 1 |
| Clinical Stage Products | 42 | 1 |
| Early Stage Products | 43 | 1 |
| Malaria Products under Development by Companies | 44 | 7 |
| Malaria Products under Investigation by Universities/Institutes | 51 | 7 |
| Malaria Companies Involved in Therapeutics Development | 58 | 63 |
| 4SC AG | 58 | 1 |
| Acetylon Pharmaceuticals, Inc. | 59 | 1 |
| Actelion Ltd | 60 | 1 |
| Agilvax Inc | 61 | 1 |
| Akshaya Bio Inc. | 62 | 1 |
| Allergy Therapeutics Plc | 63 | 1 |
| Amura Holdings Limited | 64 | 1 |
| Anacor Pharmaceuticals, Inc. | 65 | 1 |
| Artificial Cell Technologies, Inc. | 66 | 1 |
| AstraZeneca Plc | 67 | 1 |
| Bharat Biotech International Limited | 68 | 1 |
| Callaghan Innovation Research Ltd. | 69 | 1 |
| Carna Biosciences, Inc. | 70 | 1 |
| CEL-SCI Corporation | 71 | 1 |
| Celgene Corporation | 72 | 1 |
| Cellceutix Corporation | 73 | 1 |
| Chong Kun Dang Pharmaceutical Corp. | 74 | 1 |
| Cilian AG | 75 | 1 |
| Daiichi Sankyo Company, Limited | 76 | 1 |
| DesignMedix, Inc. | 77 | 1 |
| Eisai Co., Ltd. | 78 | 1 |
| GenVec, Inc. | 79 | 1 |
| Genzyme Corporation | 80 | 1 |
| GlaxoSmithKline Plc | 81 | 1 |
| Hager Biosciences, LLC | 82 | 1 |
| Horizon Pharma Plc | 83 | 1 |
| iBio, Inc. | 84 | 1 |
| Imaxio SA | 85 | 1 |
| Immtech Pharmaceuticals, Inc. | 86 | 1 |
| Immunovaccine Inc | 87 | 1 |
| IPCA Laboratories Limited | 88 | 1 |
| IRBM Science Park SpA | 89 | 1 |
| Jenrin Discovery, Inc. | 90 | 1 |
| Jomaa Pharma GmbH | 91 | 1 |
| Kancera AB | 92 | 1 |
| Kymab Limited | 93 | 1 |
| Lipocure Ltd. | 94 | 1 |
| Lipotek Pty Ltd. | 95 | 1 |
| LondonPharma Ltd | 96 | 1 |
| Merck &Co., Inc. | 97 | 1 |
| Merck KGaA | 98 | 1 |
| MerLion Pharmaceuticals Pte Ltd | 99 | 1 |
| Microbiotix, Inc. | 100 | 1 |
| Mitsubishi Tanabe Pharma Corporation | 101 | 1 |
| Mucosis B.V. | 102 | 1 |
| Mymetics Corporation | 103 | 1 |
| Novartis AG | 104 | 1 |
| PaxVax, Inc. | 105 | 1 |
| Pfenex Inc. | 106 | 1 |
| Pfizer Inc. | 107 | 1 |
| Protein Potential, LLC | 108 | 1 |
| Rodos BioTarget GmbH | 109 | 1 |
| Sanaria Inc. | 110 | 1 |
| Sanofi | 111 | 1 |
| SBI Pharmaceuticals Co., Ltd. | 112 | 1 |
| Selecta Biosciences, Inc. | 113 | 1 |
| Sigma-Tau S.p.A. | 114 | 1 |
| Takeda Pharmaceutical Company Limited | 115 | 1 |
| Telormedix SA | 116 | 1 |
| Tomegavax, Inc. | 117 | 1 |
| VLP Biotech, Inc. | 118 | 1 |
| VLP Therapeutics, LLC | 119 | 1 |
| Zydus Cadila Healthcare Limited | 120 | 1 |
| Malaria Therapeutics Assessment | 121 | 12 |
| Assessment by Monotherapy Products | 121 | 1 |
| Assessment by Combination Products | 122 | 1 |
| Assessment by Target | 123 | 3 |
| Assessment by Mechanism of Action | 126 | 3 |
| Assessment by Route of Administration | 129 | 2 |
| Assessment by Molecule Type | 131 | 2 |
| Drug Profiles | 133 | 251 |
| (aminolevulinic acid hydrochloride + sodium ferrous citrate) Drug Profile | 133 | 1 |
| (artenimol + piperaquine) Drug Profile | 134 | 1 |
| ACT-451840 Drug Profile | 135 | 1 |
| Alaremycin Drug Profile | 136 | 1 |
| AN-13762 Drug Profile | 137 | 1 |
| AN-6426 Drug Profile | 138 | 1 |
| AN-8432 Drug Profile | 139 | 1 |
| Antibodies for Malaria Drug Profile | 140 | 1 |
| AQ-13 Drug Profile | 141 | 1 |
| artefenomel Drug Profile | 142 | 1 |
| artefenomel + ferroquine Drug Profile | 143 | 1 |
| artemether Drug Profile | 144 | 2 |
| AX-05 Drug Profile | 146 | 1 |
| BDM-I Drug Profile | 147 | 2 |
| BIX-01294 Drug Profile | 149 | 1 |
| BKSE-36 Drug Profile | 150 | 1 |
| BPH-703 Drug Profile | 151 | 1 |
| bromophycolide A Drug Profile | 152 | 1 |
| CDRI-99/411 Drug Profile | 153 | 1 |
| CEL-1000 Drug Profile | 154 | 2 |
| cipargamin Drug Profile | 156 | 1 |
| CWHM-123 Drug Profile | 157 | 1 |
| CWHM-505 Drug Profile | 158 | 1 |
| cysteamine DR Drug Profile | 159 | 8 |
| DDD-498 Drug Profile | 167 | 1 |
| DLANA-14 Drug Profile | 168 | 1 |
| DM-1157 Drug Profile | 169 | 1 |
| DSM-265 Drug Profile | 170 | 2 |
| DSM-421 Drug Profile | 172 | 1 |
| E-209 Drug Profile | 173 | 1 |
| E-6446 Drug Profile | 174 | 1 |
| EDE-1304 Drug Profile | 175 | 1 |
| ELQ-300 Drug Profile | 176 | 1 |
| Falcitidin Drug Profile | 177 | 1 |
| fosmidomycin Drug Profile | 178 | 2 |
| fumarranol Drug Profile | 180 | 1 |
| Gene Therapy for Infectious Disease, Gastrointestinal and Metabolic Disorders Drug Profile | 181 | 1 |
| GENZ-644131 Drug Profile | 182 | 1 |
| GENZ-644442 Drug Profile | 183 | 1 |
| GIBH-117 Drug Profile | 184 | 1 |
| GSK-030 Drug Profile | 185 | 1 |
| GSK-3191607 Drug Profile | 186 | 1 |
| GSK-692 Drug Profile | 187 | 1 |
| hypoestoxide Drug Profile | 188 | 1 |
| IMX-313-ML Drug Profile | 189 | 1 |
| JAIVAC-2 Drug Profile | 190 | 1 |
| JAIVAC 1 Drug Profile | 191 | 1 |
| JD-3000 Series Drug Profile | 192 | 1 |
| KAF-156 Drug Profile | 193 | 1 |
| KAI-407 Drug Profile | 194 | 1 |
| KNI-10006 Drug Profile | 195 | 1 |
| KNI-727 Drug Profile | 196 | 1 |
| mAb-5D5 Drug Profile | 197 | 1 |
| malaria (virus like particle) vaccine Drug Profile | 198 | 1 |
| malaria [strain 7G8] vaccine Drug Profile | 199 | 1 |
| malaria [strain FVO] vaccine Drug Profile | 200 | 2 |
| malaria [strain Salvador I] vaccine Drug Profile | 202 | 1 |
| malaria vaccine Drug Profile | 203 | 2 |
| malaria vaccine Drug Profile | 205 | 1 |
| malaria vaccine Drug Profile | 206 | 1 |
| malaria vaccine Drug Profile | 207 | 1 |
| malaria vaccine Drug Profile | 208 | 1 |
| malaria vaccine Drug Profile | 209 | 2 |
| malaria vaccine Drug Profile | 211 | 1 |
| malaria vaccine Drug Profile | 212 | 1 |
| malaria vaccine Drug Profile | 213 | 1 |
| malaria vaccine Drug Profile | 214 | 1 |
| malaria vaccine Drug Profile | 215 | 1 |
| malaria vaccine Drug Profile | 216 | 1 |
| malaria vaccine Drug Profile | 217 | 1 |
| malaria vaccine Drug Profile | 218 | 1 |
| malaria vaccine Drug Profile | 219 | 1 |
| malaria vaccine Drug Profile | 220 | 1 |
| malaria vaccine Drug Profile | 221 | 1 |
| malaria vaccine Drug Profile | 222 | 1 |
| malaria vaccine Drug Profile | 223 | 1 |
| malaria vaccine Drug Profile | 224 | 1 |
| malaria vaccine Drug Profile | 225 | 1 |
| malaria vaccine Drug Profile | 226 | 1 |
| malaria vaccine Drug Profile | 227 | 1 |
| malaria vaccine Drug Profile | 228 | 1 |
| malaria vaccine Drug Profile | 229 | 1 |
| malaria vaccine Drug Profile | 230 | 1 |
| malaria vaccine Drug Profile | 231 | 1 |
| malaria vaccine Drug Profile | 232 | 1 |
| malaria vaccine Drug Profile | 233 | 1 |
| malaria vaccine Drug Profile | 234 | 1 |
| malaria vaccine Drug Profile | 235 | 1 |
| malaria vaccine 1 Drug Profile | 236 | 1 |
| malaria vaccine 1 Drug Profile | 237 | 1 |
| malaria vaccine 1 Drug Profile | 238 | 1 |
| malaria vaccine 1 Drug Profile | 239 | 1 |
| malaria vaccine 1 Drug Profile | 240 | 1 |
| malaria vaccine 2 Drug Profile | 241 | 7 |
| malaria vaccine 2 Drug Profile | 248 | 1 |
| malaria vaccine 3 Drug Profile | 249 | 1 |
| malaria vaccine 4 Drug Profile | 250 | 1 |
| malaria vaccine 5 Drug Profile | 251 | 1 |
| malaria vaccine 5 Drug Profile | 252 | 2 |
| malaria vaccine 6 Drug Profile | 254 | 1 |
| malarial vaccine Drug Profile | 255 | 1 |
| MaX-04 Drug Profile | 256 | 1 |
| MDN-0104 Drug Profile | 257 | 1 |
| methylprednisolone sodium phosphate Drug Profile | 258 | 1 |
| ML-276 Drug Profile | 259 | 1 |
| MMV-000248 Drug Profile | 260 | 1 |
| MMV-253 Drug Profile | 261 | 1 |
| MMV-390048 Drug Profile | 262 | 1 |
| MS-08 Drug Profile | 263 | 1 |
| N-251 Drug Profile | 264 | 1 |
| N-89 Drug Profile | 265 | 1 |
| NCK-8 Drug Profile | 266 | 1 |
| nepodin Drug Profile | 267 | 1 |
| neuregulin-1 Drug Profile | 268 | 1 |
| NPC-1161B Drug Profile | 269 | 1 |
| P-218 Drug Profile | 270 | 1 |
| PA-92 Drug Profile | 271 | 1 |
| PEV-3 Drug Profile | 272 | 2 |
| PEV-3B Drug Profile | 274 | 1 |
| PMX-1207 Drug Profile | 275 | 1 |
| PMX-207 Drug Profile | 276 | 1 |
| PMX-30024 Drug Profile | 277 | 1 |
| Polymer for Malaria Drug Profile | 278 | 1 |
| PQ-1 Drug Profile | 279 | 1 |
| Protein to Inhibit Phospholipase A2 for Malaria Drug Profile | 280 | 1 |
| PW-28 Drug Profile | 281 | 1 |
| Px-533 Drug Profile | 282 | 1 |
| R-21 Drug Profile | 283 | 1 |
| RBT-06 Drug Profile | 284 | 1 |
| RKA-182 Drug Profile | 285 | 1 |
| RRX-001 Drug Profile | 286 | 2 |
| S-0110725 Drug Profile | 288 | 1 |
| S-0111793 Drug Profile | 289 | 1 |
| SJ-733 Drug Profile | 290 | 1 |
| Small Molecule 1 for Malaria Drug Profile | 291 | 1 |
| Small Molecule 2 for Malaria Drug Profile | 292 | 1 |
| Small Molecule 2 to Inhibit CaM Kinase for Malaria Drug Profile | 293 | 1 |
| Small Molecule for Malaria Drug Profile | 294 | 1 |
| Small Molecule for Malaria Drug Profile | 295 | 1 |
| Small Molecule for Malaria Drug Profile | 296 | 1 |
| Small Molecule for Malaria Drug Profile | 297 | 1 |
| Small Molecule for Malaria Drug Profile | 298 | 1 |
| Small Molecule for Malaria Drug Profile | 299 | 1 |
| Small Molecule for Malaria and Bacterial Infections Drug Profile | 300 | 1 |
| Small Molecule to Inhibit CDPK1 for Malaria Drug Profile | 301 | 1 |
| Small Molecule to Inhibit GWT1 Protein for Malaria Drug Profile | 302 | 1 |
| Small Molecule to Inhibit Histone Deacetylase for Malaria Drug Profile | 303 | 1 |
| Small Molecule to Inhibit Hypoxanthine Phosphoribosyltransferase for Malaria Drug Profile | 304 | 1 |
| Small Molecule to Inhibit Kinase for Malaria Drug Profile | 305 | 1 |
| Small Molecule to Inhibit Proteasome for Malaria Drug Profile | 306 | 1 |
| Small Molecules 1 for Malaria Drug Profile | 307 | 1 |
| Small Molecules 2 for Malaria Drug Profile | 308 | 1 |
| Small Molecules 3 for Malaria Drug Profile | 309 | 1 |
| Small Molecules for Bacterial Infections and Malaria Drug Profile | 310 | 1 |
| Small Molecules for Infectious Diseases Drug Profile | 311 | 1 |
| Small Molecules for Malaria Drug Profile | 312 | 1 |
| Small Molecules for Malaria Drug Profile | 313 | 1 |
| Small Molecules for Malaria Drug Profile | 314 | 1 |
| Small Molecules for Malaria Drug Profile | 315 | 1 |
| Small Molecules for Malaria Drug Profile | 316 | 1 |
| Small Molecules for Malaria Drug Profile | 317 | 2 |